ATE314071T1 - Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten - Google Patents
Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonistenInfo
- Publication number
- ATE314071T1 ATE314071T1 AT97937153T AT97937153T ATE314071T1 AT E314071 T1 ATE314071 T1 AT E314071T1 AT 97937153 T AT97937153 T AT 97937153T AT 97937153 T AT97937153 T AT 97937153T AT E314071 T1 ATE314071 T1 AT E314071T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- combination
- receptor antagonists
- respiratory tract
- allergic reactions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68995196A | 1996-08-16 | 1996-08-16 | |
PCT/US1997/013903 WO1998006394A1 (en) | 1996-08-16 | 1997-08-13 | Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE314071T1 true ATE314071T1 (de) | 2006-01-15 |
Family
ID=24770500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97937153T ATE314071T1 (de) | 1996-08-16 | 1997-08-13 | Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0920315B1 (de) |
JP (2) | JP3638289B2 (de) |
KR (1) | KR20000029975A (de) |
CN (1) | CN1152682C (de) |
AR (1) | AR008293A1 (de) |
AT (1) | ATE314071T1 (de) |
AU (1) | AU722040B2 (de) |
BR (1) | BR9711149A (de) |
CA (1) | CA2263163A1 (de) |
CO (1) | CO4910138A1 (de) |
CZ (1) | CZ43299A3 (de) |
DE (1) | DE69734984D1 (de) |
HU (1) | HUP9904362A3 (de) |
ID (1) | ID17871A (de) |
IL (1) | IL128573A0 (de) |
MY (1) | MY116130A (de) |
NO (1) | NO990706L (de) |
NZ (1) | NZ334063A (de) |
PE (1) | PE100298A1 (de) |
PL (1) | PL191073B1 (de) |
SK (1) | SK20099A3 (de) |
TR (1) | TR199900326T2 (de) |
TW (2) | TW200427450A (de) |
WO (1) | WO1998006394A1 (de) |
ZA (1) | ZA977263B (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042379A2 (en) * | 1997-03-26 | 1998-10-01 | Sepracor Inc. | Chemically and thermally stable norastemizole formulations |
KR100514264B1 (ko) * | 1997-08-26 | 2005-09-15 | 아벤티스 파마슈티칼스 인크. | 피페리디노알칸올-충혈완화제 조합용 제약 조성물 |
US5990147A (en) * | 1997-11-07 | 1999-11-23 | Schering Corporation | H3 receptor ligands of the phenyl-alkyl-imidazoles type |
US6034251A (en) * | 1997-11-07 | 2000-03-07 | Schering Corporation | Phenyl-alkyl-imidazoles |
ES2188029T3 (es) * | 1997-11-07 | 2003-06-16 | Schering Corp | Fenil-alquil-imidazoles como antagonistas del receptor h3. |
TW421645B (en) * | 1997-11-07 | 2001-02-11 | Schering Corp | H3 receptor ligands of the phenyl-alkyl-imidazoles type |
IL135727A0 (en) * | 1997-11-07 | 2001-05-20 | Schering Corp | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
US6384038B1 (en) * | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
JP2002527381A (ja) * | 1998-10-09 | 2002-08-27 | シェーリング コーポレイション | アレルギー性疾患を処置するための組成物および方法 |
US6100279A (en) * | 1998-11-05 | 2000-08-08 | Schering Corporation | Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
WO2001021162A2 (en) * | 1999-09-22 | 2001-03-29 | Schering Corporation | Treating allergic and inflammatory conditions using desloratadine |
AU3800601A (en) | 2000-02-03 | 2001-08-14 | Schering Corporation | Treating allergic and inflammatory conditions |
PE20020507A1 (es) | 2000-10-17 | 2002-06-25 | Schering Corp | Compuestos no-imidazoles como antagonistas del receptor histamina h3 |
GB2373186A (en) * | 2001-02-23 | 2002-09-18 | Astrazeneca Ab | Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation |
AU2002244271A1 (en) | 2001-03-13 | 2002-09-24 | Pharmacopeia, Inc. | Non-imidazole compounds as histamine h3 antagonists |
US7105505B2 (en) | 2002-04-18 | 2006-09-12 | Schering Corporation | Benzimidazole derivatives useful as histamine H3 antagonists |
PE20040464A1 (es) | 2002-04-18 | 2004-07-24 | Schering Corp | Benzimidazolonas sustituidas y derivados como antagonistas de histamina h3 |
MY135686A (en) | 2002-06-24 | 2008-06-30 | Schering Corp | Indole derivatives useful as histamine h3 antagonists |
US20050090527A1 (en) * | 2003-01-28 | 2005-04-28 | Schering Corporation | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
WO2007001975A1 (en) | 2005-06-20 | 2007-01-04 | Schering Corporation | Piperidine derivatives useful as histamine h3 antagonists |
US20110166124A1 (en) | 2008-07-23 | 2011-07-07 | Mccormick Kevin D | Tricyclic spirocycle derivatives and methods of use |
WO2010045306A2 (en) | 2008-10-16 | 2010-04-22 | Schering Corporation | Azine derivatives and methods of use thereof |
US8283360B2 (en) | 2008-12-19 | 2012-10-09 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic derivatives and methods of use thereof |
EP2379565A1 (de) | 2008-12-19 | 2011-10-26 | Schering Corporation | Piperidin- und piperazinderivate und verfahren zu deren verwendung |
US8569273B2 (en) | 2009-03-17 | 2013-10-29 | Aciex Therapeutics, Inc. | Ophthalmic formulations of cetirizine and methods of use |
PT2408453T (pt) | 2009-03-17 | 2022-04-05 | Nicox Ophthalmics Inc | Formulações oftálmicas de cetirizina e métodos de utilização |
EP2429530B1 (de) * | 2009-05-14 | 2018-11-07 | The General Hospital Corporation | (s)-meclozin zur behandlung von ischämischen reperfusions-schäden |
EP2485735B1 (de) | 2009-10-08 | 2015-07-29 | Merck Sharp & Dohme Corp. | Hemmer von fettsäurebindenden proteinen (fabp) |
WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
RU2685277C1 (ru) * | 2018-05-24 | 2019-04-17 | Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" | Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201683B (en) * | 1987-08-04 | 1990-12-28 | Biogal Gyogyszergyar | Process for producing pharmaceutical compositions for promoting healing of wounds |
US5019591A (en) * | 1989-02-17 | 1991-05-28 | Pennsylvania Research Corporation | Method for treating retinopathy and other small vessel disorders associated with diabetes |
GB9303210D0 (en) * | 1993-02-17 | 1993-03-31 | Univ Manitoba | Cancer treatment |
-
1997
- 1997-08-13 EP EP97937153A patent/EP0920315B1/de not_active Expired - Lifetime
- 1997-08-13 NZ NZ334063A patent/NZ334063A/xx unknown
- 1997-08-13 CA CA002263163A patent/CA2263163A1/en not_active Abandoned
- 1997-08-13 AT AT97937153T patent/ATE314071T1/de not_active IP Right Cessation
- 1997-08-13 TW TW093112764A patent/TW200427450A/zh unknown
- 1997-08-13 DE DE69734984T patent/DE69734984D1/de not_active Expired - Lifetime
- 1997-08-13 CZ CZ99432A patent/CZ43299A3/cs unknown
- 1997-08-13 BR BR9711149A patent/BR9711149A/pt not_active Application Discontinuation
- 1997-08-13 KR KR1019997001226A patent/KR20000029975A/ko active IP Right Grant
- 1997-08-13 TW TW086111627A patent/TWI221768B/zh not_active IP Right Cessation
- 1997-08-13 AR ARP970103693A patent/AR008293A1/es unknown
- 1997-08-13 MY MYPI97003708A patent/MY116130A/en unknown
- 1997-08-13 AU AU39733/97A patent/AU722040B2/en not_active Ceased
- 1997-08-13 ZA ZA9707263A patent/ZA977263B/xx unknown
- 1997-08-13 WO PCT/US1997/013903 patent/WO1998006394A1/en not_active Application Discontinuation
- 1997-08-13 IL IL12857397A patent/IL128573A0/xx unknown
- 1997-08-13 CN CNB971987130A patent/CN1152682C/zh not_active Expired - Fee Related
- 1997-08-13 PE PE1997000705A patent/PE100298A1/es not_active Application Discontinuation
- 1997-08-13 PL PL331617A patent/PL191073B1/pl not_active IP Right Cessation
- 1997-08-13 TR TR1999/00326T patent/TR199900326T2/xx unknown
- 1997-08-13 HU HU9904362A patent/HUP9904362A3/hu unknown
- 1997-08-13 JP JP50985998A patent/JP3638289B2/ja not_active Expired - Fee Related
- 1997-08-13 SK SK200-99A patent/SK20099A3/sk unknown
- 1997-08-14 CO CO97046887A patent/CO4910138A1/es unknown
- 1997-08-14 ID IDP972837A patent/ID17871A/id unknown
-
1999
- 1999-02-15 NO NO990706A patent/NO990706L/no unknown
-
2002
- 2002-07-30 JP JP2002222138A patent/JP2003095979A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2003095979A (ja) | 2003-04-03 |
NO990706D0 (no) | 1999-02-15 |
EP0920315B1 (de) | 2005-12-28 |
AR008293A1 (es) | 1999-12-29 |
PL331617A1 (en) | 1999-08-02 |
CN1233179A (zh) | 1999-10-27 |
CA2263163A1 (en) | 1998-02-19 |
BR9711149A (pt) | 1999-08-17 |
JP2000505094A (ja) | 2000-04-25 |
WO1998006394A1 (en) | 1998-02-19 |
DE69734984D1 (de) | 2006-02-02 |
NO990706L (no) | 1999-02-15 |
TW200427450A (en) | 2004-12-16 |
PE100298A1 (es) | 1999-01-11 |
TR199900326T2 (xx) | 1999-05-21 |
AU3973397A (en) | 1998-03-06 |
HUP9904362A2 (hu) | 2000-11-28 |
AU722040B2 (en) | 2000-07-20 |
CZ43299A3 (cs) | 1999-07-14 |
KR20000029975A (ko) | 2000-05-25 |
PL191073B1 (pl) | 2006-03-31 |
JP3638289B2 (ja) | 2005-04-13 |
CN1152682C (zh) | 2004-06-09 |
CO4910138A1 (es) | 2000-04-24 |
NZ334063A (en) | 2000-09-29 |
HUP9904362A3 (en) | 2000-12-28 |
TWI221768B (en) | 2004-10-11 |
EP0920315A1 (de) | 1999-06-09 |
IL128573A0 (en) | 2000-01-31 |
MY116130A (en) | 2003-11-28 |
ID17871A (id) | 1998-02-05 |
ZA977263B (en) | 1998-02-16 |
SK20099A3 (en) | 2000-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69734984D1 (de) | Behandlung von allergischen reaktionen im oberen respirationstrakt mit einer kombination von histamin-rezeptor-antagonisten | |
EP0230370A3 (en) | Use of specific n-methyl-d-aspartate receptor antagonists in the prevention and treatment of neurodegeneration | |
DE60033947D1 (de) | Dosierungsform und verfahren zu einer effektiven reboxetintherapie mit einer "einmal täglich" dosierung | |
CY2015056I1 (el) | Ανασυνδυασμενοι antαγωνιστες της il-5 που ειναι χρησιμοι στη θεραπεια διαταραχων που διαμεσολαβουνται απο την il-5 | |
ITRM940356A0 (it) | "perfezionamento nei sistemi stimolatori cardiaci".- | |
DE69733775D1 (de) | Titandioxidteilchen mit verklebenden diskreten anorganischen teilchen | |
DE69509765T2 (de) | N-heterocyclyl sulphonamid-derivate und ihre verwendung als endothelin-antagonisten | |
ATE326468T1 (de) | Pyridon-kondensierte azabicyclische- oder cytisin-derivate, ihre herstellung und verwendung in der suchttherapie | |
NO975976L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
FI963511A (fi) | Pakko-oireisten häiriöiden hoito 5-HT2-antagonisteilla | |
MA23172A1 (fr) | Antagonistes de recepteurs d'endotheline . | |
IL111379A0 (en) | Histamine h3-receptor antagonists and therapeutic uses thereof | |
DE19653645A1 (de) | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung | |
Horlacher | Metric Irregularity in" Les noces": The Problem of Periodicity | |
DE59811722D1 (de) | Abbildende und/oder abtastende vorrichtung mit einer kompensierung von, durch die umgebung verursachter abbildungsverschlechterungen | |
DE69133390D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorragischem schlaganfall | |
NO892542D0 (no) | Fremgangsmaate for fremstilling av neurokinin a antagonister. | |
DE69125175D1 (de) | Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen | |
NO20020008D0 (no) | Anvendelse av cortisol antagonister i behandling av hjertesvikt | |
FI953720A0 (fi) | Neurotensiiniantagonistien käyttö diureettietan lääkkeiden valmistamiseksi | |
DE69600374T2 (de) | Zubereitung in Form von einer weichen Paste und Herstellungsverfahren | |
DE69801173D1 (de) | Gerät zur Rettung und Bergung von ins Wasser gefallenen Personen | |
DE59503551D1 (de) | Vorrichtung zur diskontinuierlichen zubereitung von teigwaren und portioniervorrichtung zur verwendung mit einer solchen vorrichtung | |
DK210587A (da) | Biocide midler, samt anvendelse deraf | |
DK49089A (da) | Leukotrien-b4-antagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |